Table 2.
Treatment | (mg/kg) | [DOPAC]/[DA] | [3-MT]/[DA] | [3-MT]/[DOPAC] | [HVA]/[DA] |
---|---|---|---|---|---|
Hippocampus | |||||
Vehicle | 0 | 28 ± 5.1 | 1.7 ± 0.6 | 8 ± 2.8 | 56 ± 14.2 |
EMD386088 | 2.5 | 9 ± 1.2** | 2.7 ± 0.9 | 27 ± 7.4* | 22 ± 1.6* |
5 | 10 ± 1.0** | 2.0 ± 1.3 | 23 ± 16.3 | 27 ± 2.1* | |
F(2, 20) = 11.03 p < 0.001 |
F(2, 20) = 0.28 NS |
F(2, 20) = 4.11 p < 0.05 |
F(2, 20) = 4.53 p < 0.01 |
||
Nucleus accumbens | |||||
Vehicle | 0 | 21 ± 0.7 | 1.4 ± 0.1 | 7 ± 0.3 | 12 ± 0.8 |
EMD386088 | 2.5 | 18 ± 0.4** | 1.7 ± 0.2 | 10 ± 0.9.** | 9 ± 0.4** |
5 | 16 ± 0.7** | 1.4 ± 0.1 | 9 ± 0.1* | 8 ± 0.5** | |
F(2,21) = 18.3 p < 0.0001 |
F(2, 21) = 2.52 NS |
F(2, 21) = 6.81 p < 0.01 |
F(2, 21) = 14.54 p < 0.0001 |
||
Striatum | |||||
Vehicle | 0 | 15 ± 0.3 | 2.9 ± 0.1 | 19 ± 0.6 | 13 ± 0.7 |
EMD386088 | 2.5 | 14 ± 0.4* | 3.3 ± 0.1 | 23 ± 0.5** | 10 ± 0.7* |
5 | 13 ± 0.4** | 2.9 ± 0.1 | 23 ± 0.7** | 10 ± 0.6* | |
F(2, 21) = 13.99 p < 0.0001 |
F(2, 21) = 3.88 p < 0.05 |
F(2, 21) = 13.68 p < 0.0001 |
F(2, 21) = 4.35 p < 0.05 |
EMD386088 was injected i.p. in a dose of 2.5 and 5 mg/kg; control group was treated i.p. with saline. The rats were decapitated about 30 min after drug injection. The results are expressed as the mean ± SEM (N = 8). The rate of DA total metabolism was expressed as the ratio [HVA] / [DA] × 100; the rate of DA MAO-dependent oxidation as the ratio: [DOPAC] / [DA] × 100; the rate of the inhibition of dopamine reuptake as the ratio: [3-MT] / [DOPAC] × 100; and the rate of COMT-dependent O-methylation as the ratio: [3-MT] / [DA] × 100. The indices were calculated using concentrations from individual tissue samples. The data were analyzed by means of one-way ANOVA, followed by Duncan’s post hoc test
NS not significant
Statistical significance: *p < 0.05, **p < 0.01 vs. respective control group